- Home
- XOMA
XOMA
XOMA Corporation
as 11-07-2025 3:53pm EST
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.
| Founded: | 1981 | Country: | United States |
| Employees: | N/A | City: | EMERYVILLE |
| Market Cap: | 457.6M | IPO Year: | N/A |
| Target Price: | $69.50 | AVG Volume (30 days): | 43.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.37 | EPS Growth: | N/A |
| 52 Week Low/High: | $18.35 - $39.92 | Next Earning Date: | 11-05-2025 |
| Revenue: | $44,952,000 | Revenue Growth: | 194.98% |
| Revenue Growth (this year): | 88.91% | Revenue Growth (next year): | 13.80% |
Latest XOMA Corporation News
XOMA Breaking Stock News: Dive into XOMA Ticker-Specific Updates for Smart Investing
Zacks
4 days ago
Tango Therapeutics, Inc. (TNGX) Tops Q3 Earnings and Revenue Estimates
MT Newswires
22 days ago
XOMA Royalty Lowers Cash Offer for Lava Therapeutics, Extends Tender Deadline
GlobeNewswire
22 days ago
XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement
MT Newswires
a month ago
XOMA Royalty Extends Tender Offer to Acquire Lava Therapeutics
MT Newswires
4 months ago
Xoma Royalty Agrees to Acquire Turnstone Biologics
GlobeNewswire
4 months ago
Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right
Zacks
4 months ago
XOMA Royalty (XOMA) Moves 9.0% Higher: Will This Strength Last?
GlobeNewswire
5 months ago
XOMA Royalty Declares Quarterly Preferred Stock Dividends
Compare XOMA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "XOMA XOMA Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.